BIPASS Trademark

Trademark Overview

On Thursday, June 26, 2025, a trademark application was filed for BIPASS with the United States Patent and Trademark Office. The USPTO has given the BIPASS trademark a serial number of 79428881. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, July 31, 2025. This trademark is owned by Telix Pharmaceuticals Limited. The BIPASS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research in the nature of conducting clinical trials for others in the field of cancer; clinical research in the field of cancer; testing of pharmaceuticals; laboratory testing; medical research; pharmaceutical research consultancy; research and development in the field of pharmaceuticals.
bipass

General Information

Serial Number79428881
Word MarkBIPASS
Filing DateThursday, June 26, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, July 31, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesScientific research in the nature of conducting clinical trials for others in the field of cancer; clinical research in the field of cancer; testing of pharmaceuticals; laboratory testing; medical research; pharmaceutical research consultancy; research and development in the field of pharmaceuticals.

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 11, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTelix Pharmaceuticals Limited
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressAU

Trademark Events

Event DateEvent Description
Monday, August 11, 2025LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, August 14, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 14, 2025APPLICATION FILING RECEIPT MAILED
Thursday, July 31, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

bipass research field pharmaceuticals testing cancer clinical medical pharmaceutical consultancy development